Peter Hunt

Aug 6, 2024 | drugscience.org.uk | David Nutt |Tadeusz Hawrot |Peter Hunt

AuthorsProf David J NuttImperial College London; Drug Science Tadeusz HawrotPAREAPeter HuntMind Medicine Australia Dr Anne Katrin SchlagImperial College London; Drug SciencePublishedAugust 6, 2024MDMA [now called midomafetamine by the FDA] is a substituted amphetamine first synthesized in 1912 by Merck that has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies (MAPS) as a novel treatment for post-traumatic stress disorder (PTSD).

Jun 3, 2024 | mdpi.com | Peter Hunt |Mohammad Noori |Scott J. Hazelwood |Naudereh Noori

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

May 2, 2023 | frontiersin.org | Peter Hunt |Julia Blanco |Souheil-Antoine Younes

Liting Yan1,2*, Kaiju Xu1,2, Qing Xiao3, Lin Tuo1,2, Tingting Luo1,2, Shuqiang Wang1,2, Renguo Yang1,2, Fujie Zhang3* and Xingxiang Yang1,2* 1Department of Infectious Disease, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China 2Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China 3Clinical and Research Center for Infectious Diseases, Beijing Ditan Hospital, Beijing, China Highly active...